EP 0904538 A4 20010411 - METHOD OF DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS USING ANTI-CHOLESTEROL ANTIBODIES
Title (en)
METHOD OF DIAGNOSIS AND TREATMENT OF ATHEROSCLEROSIS USING ANTI-CHOLESTEROL ANTIBODIES
Title (de)
BENUTZUNG VON ANTI-CHOLESTEROL-ANTIKORPERN IN EINER METHODE ZUR DIAGNOSE UND BEHANDLUNG VON ATHEROSKLEROSE
Title (fr)
METHODE DE DIAGNOSTIC ET DE TRAITEMENT DE L'ATHEROSCLEROSE A L'AIDE D'ANTICOPRS ANTI-CHOLESTEROL
Publication
Application
Priority
- US 9619381 W 19961205
- US 820395 P 19951205
- US 75956996 A 19961204
Abstract (en)
[origin: WO9721099A1] Methods of use of anti-cholesterol antibodies are described for diagnosis and treatment of atherosclerosis. In one embodiment of the invention, anti-cholesterol antibodies are used to assay samples drawn from atherosclerotic lesions for the amount of VLDL, IDL and LDL, but not HDL molecules. In another embodiment of the invention, the anti-cholesterol antibodies are used as fusiogens to promote fusion of lipoprotein molecules and of liposomes, to promote clearance of cholesterol from the body.
IPC 1-7
IPC 8 full level
G01N 33/53 (2006.01); G01N 33/92 (2006.01)
CPC (source: EP)
G01N 33/53 (2013.01); G01N 33/92 (2013.01); G01N 2800/323 (2013.01)
Citation (search report)
- [Y] EP 0621284 A1 19941026 - SHINO TEST CORP [JP]
- [Y] WO 9423302 A1 19941013 - UNIV AUSTRALIAN [AU], et al
- [Y] WO 9318067 A1 19930916 - ABBOTT LAB [US]
- [Y] SWARTZ GM ET AL: "Antibodies to cholesterol", PROC. NATL. ACAD. SCI., vol. 85, March 1988 (1988-03-01), USA, pages 1902 - 1906, XP000942042
- See references of WO 9721099A1
Designated contracting state (EPC)
DE FR GB IT
DOCDB simple family (publication)
WO 9721099 A1 19970612; AU 1409797 A 19970627; AU 713531 B2 19991202; CA 2239092 A1 19970612; EP 0904538 A1 19990331; EP 0904538 A4 20010411; JP 2002504225 A 20020205
DOCDB simple family (application)
US 9619381 W 19961205; AU 1409797 A 19961205; CA 2239092 A 19961205; EP 96944237 A 19961205; JP 52142997 A 19961205